Khalid Jamal

Dr. Khalid Jamal

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 August 2021 in Journal of Healthcare Engineering
Verified
Journal Article
Open access
PDF file
MAMian Haider Ali
Mian Haider Ali
DKDost Muhammad Khan
Dost Muhammad Khan
KJKhalid Jamal
Khalid Jamal
ZAZubair Ahmad
Zubair Ahmad
SMSadaf Manzoor
Sadaf Manzoor
ZKZardad Khan
Zardad Khan
In this paper, we have focused on machine learning (ML) feature selection (FS) algorithms for identifying and diagnosing multidrug-resistant (MDR) tuberculosis (TB). MDR-TB is a universal public health problem, and its early detection has been one of the burning issues. The present study has been conducted in the Malakand Division of Khyber Pakhtunkhwa, Pakistan, to further add to the knowledge on the disease and to deal with the issues of identification and early detection of MDR-TB by ML algorithms. These models also identify the most important factors causing MDR-TB infection whose study gives additional insights into the matter. ML algorithms such as random forest, k-nearest neighbors, support vector machine, logistic regression, leaset absolute shrinkage and selection operator (LASSO), artificial neural networks (ANNs), and decision trees are applied to analyse the case-control dataset. This study reveals that close contacts of MDR-TB patients, smoking, depression, previous TB history, improper treatment, and interruption in first-line TB treatment have a great impact on the status of MDR. Accordingly, weight loss, chest pain, hemoptysis, and fatigue are important symptoms. Based on accuracy, sensitivity, and specificity, SVM and RF are the suggested models to be used for patients classifications.

28 January 2022 in Cureus
Verified
Journal Article
Open access
KJKhalid Jamal
Khalid Jamal
MIMuhammad Imran
Muhammad Imran
SKShah Hassan Khan
Shah Hassan Khan
AMAbdul Muneem
Abdul Muneem
MKMuhammad Salman Khan
Muhammad Salman Khan
The majority of cases with tuberculous pleuritis have negative acid-fast bacilli (AFB) on smear microscopy, making the diagnosis difficult. This case report is based on the successful diagnosis and management of an extra-pulmonary (EP) multidrug-resistant tuberculosis (MDR-TB) patient with a history of lymphoma. Initial tests revealed a right-sided pleural effusion and thickening of the pleura. The closed pleural biopsy, pleural fluid histopathology, culture, and drug sensitivity testing (DST) report revealed Mycobacterium tuberculosis with isoniazid and rifampicin resistance. Based on the DST report, the patient was labeled as a case of MDR-TB and successfully managed with an individualized drug-resistant TB (DR-TB) regimen. With initial negative microscopy and GeneXpert MTB/RIF (Sunnyvale, CA: Cepheid Inc.) reports, this case demonstrated that DR-TB could exist even in the absence of risk factors. Furthermore, it also unveils the importance of line probe assays (LPAs) and culture in identifying MDR-TB. Lymphocytic/exudative pleural effusions and pleural biopsy specimens should be subjected early on to investigations like Xpert/MTB RIF, cultures, and genotypic DST to timely diagnose and treat DR-TB.

31 December 2024 in Indus Journal of Bioscience Research
Verified
Journal Article
Open access
PDF file
KJKhalid Jamal
Khalid Jamal
MKMuhammad Khalid
Muhammad Khalid
AAAbdul Ahad
Abdul Ahad
AHAzan Hassan
Azan Hassan
SKShah Hassan Khan
Shah Hassan Khan
SRSamid Ur Rehman
Samid Ur Rehman
Therapy for tuberculosis (TB) involves the application of first-line medicines (FLDs), such as isoniazid (INH), rifampicin (RIF), pyrazinamide (PZA), ethambutol (EMB), and streptomycin (SM). Second-line medications (SLDs) are employed if the first-line therapy fails or the bacteria develop resistance to the FLDs. The present research set out to evaluate the drug-resistant tuberculosis prevalence and determine the drug-resistant patterns in District Swat. Materials and Methods This was an observational, hospital-based, retrospective research of previously diagnosed cases of all Drug sensitive TB (DS-TB), MDR-TB, and XDR-TB patients provided by the Programmatic Management of Drug-Resistant TB (PMDT) Saidu Group of Teaching Hospital, Swat from January 2015 to December 2019. There were 15,567 isolates of DS-TB and MDR-TB in all from the research. The data was analyzed applying the statistical software SPSS version 25 (SPSS Inc., Chicago, IL, USA) and Microsoft Excel (Microsoft Office Professional Plus 2016). Results According to the results, between January 2014 and December 2019, a total of 15,567 patients were registered from 13 District SWAT centers, comprising 15356 (98.64%) new cases and 211 (1.36%) re-treatment cases with known age and sex. The proportion of TB in the male population (51.9%) was higher than in the female population (48.0 %). Overall treatment success rate (TSR) for PBC cases was (3097) 93.9%. Conclusion Finding the baseline susceptibility to first- and second-line medications as soon as possible is necessary to prevent developed drug resistance and unfavorable outcomes, according to the investigation's conclusion